Delivery Order SPE2DR25D3103-SPE2DR26F9K25
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Brilinta 60 mg tablets (60-count units) valued at $1,211.20 under a firm fixed-price contract type. This delivery order, which is a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX, valued at $999.999 billion through December 2026), represents a competitively awarded, non-set-aside procurement. The place...
- The Defense Logistics Agency awarded a delivery order valued at $3,936.12 to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Brilinta 60 mg tablets (60-count). The award was competitively procured with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of November 26, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this contract at its Corporate Office location. This delivery order...
- The Defense Logistics Agency awarded a $2,638.44 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Brilinta 60 mg tablets (60-count package). This is a firm fixed-price, non-set-aside contract with a completion date of December 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order as a child action under its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Brilinta 60 mg tablets (60-count units) with a ceiling value of $10,406.56. This firm fixed-price delivery order, with an ultimate completion date of December 9, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The award carries no...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 60 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $1,758.96. The award, issued on November 3, 2025, is set to be completed by November 4, 2025. This delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Brilinta 60 mg tablets (60-count packages) with a ceiling value of $3,994.38. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is due for completion by October 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Brilinta is an antiplatelet...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Brilinta 60 mg tablets in quantities of 60 units, with a contract ceiling value of $1,387.10. This competitively awarded, firm fixed-price delivery order is set to be completed by September 15, 2025, and represents fulfillment under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Brilinta 90 mg tablets (60-count) with a ceiling value of $3,498.37. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The order is set for ultimate completion by December 11, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,188.39 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packaging) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Brilinta 90mg tablets in quantities of 60 units, with a ceiling value of $1,830.38. This firm fixed price, competitively awarded delivery order is set to be completed by November 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9K25Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Brilinta 60 mg tablets (60-count packages) with a ceiling value of $3,794.28. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procedures. The contract is scheduled for ultimate completion on December 1, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its comprehensive portfolio of pharmaceutical products and medical supplies. The company regularly fulfills delivery orders for the Defense Logistics Agency's medical supply chain, supporting military healthcare systems and other government healthcare organizations. Brilinta is a cardiovascular medication used for acute coronary syndrome treatment, representing the type of specialty pharmaceutical product within AmerisourceBergen's extensive federal supply network. The company's established capacity and track record of competitively awarded contracts demonstrate its capability to meet federal procurement requirements across diverse therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 11/27/25 |